{"contentid": 487942, "importid": NaN, "name": "Merck KGaA keeps building with \u00e2\u0080\u0098superb business results\u00e2\u0080\u0099", "introduction": "German science and technology company Merck KGaA has reported impressive sales and earnings figures in its latest quarterly and full-year 2020 financial results.", "content": "<p>German science and technology company Merck KGaA (MRK: DE) has reported impressive sales and earnings figures in its latest quarterly and full-year 2020 financial results.</p>\n<p>The group&rsquo;s adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) in 2020 rose 18.6% to 5.2 billion euros ($6.27 billion), meeting average analyst expectations. For the fourth quarter, this figure was 1.2 billion euros, a rise of 3.3%.</p>\n<p><span class=\"pullQuote\">\"Our focus on innovation-driven specialty businesses is paying off\"</span>Group sales for the year rose by 8.6% to 17.5 billion euros, while for the fourth quarter they were 5% higher than in the same period of 2019.</p>\n<p>For 2021, Merck expects earnings before interest, taxes, depreciation and amortisation (EBITDA) adjusted for one offs, to grow in the high single-digit to low teens percentage range, based on strong organic sales growth.</p>\n<p>Shares in the group were relatively unchanged as Thursday&rsquo;s trading neared the mid-point.</p>\n<p>Stefan Oschmann (pictured), chairman of the executive board and chief executive of Merck, said: &ldquo;The year 2020 was characterized by unprecedented turbulence. Yet despite the circumstances of the pandemic, we resolutely executed our strategy further and achieved truly superb business results.</p>\n<p>&ldquo;Particularly the past 12 months have once again uniquely proven the performance capability of our differentiated business model comprising three strong business sectors. Our focus on innovation-driven specialty businesses is paying off. Merck is very well positioned for a successful future.&rdquo;</p>\n<h2>Selected Healthcare product sales for full year 2020</h2>\n<p>Erbitux (cetuximab): 891 million euros, up 2.3%</p>\n<p>Bavencio (avelumab): 156 million euros, up 52.5%</p>\n<p>Mavenclad (cladribine): 531 million euros, up 65.4%</p>\n<p>Glucophage (metformin): 903 million euros, up 3.1%</p>\n<p>&nbsp;</p>", "date": "2021-03-04 12:20:00", "meta_title": NaN, "meta_keywords": "Merck, sales, euros, KGaA, earnings, business, billion, results, results\u00e2\u0080\u0099, building, German, science, technology, reported, impressive, figures, company", "meta_description": "German science and technology company Merck KGaA has reported impressive sales and earnings figures in its latest quarterly and full-year 2020 financial results", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-04 12:15:59", "updated": "2021-03-04 12:40:11", "access": NaN, "url": "https://www.thepharmaletter.com/article/merck-kgaa-keeps-building-with-superb-business-results", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "2020_oschmann_stefan_merck_kgaa_large.jpg", "image2id": "2020_oschmann_stefan_merck_kgaa_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Diabetes, Oncology, Reproductive", "topic_tag": "Financial, Management", "geography_tag": "Germany", "company_tag": "Merck KGaA", "drug_tag": "Bavencio, Erbitux, Glucophage, Mavenclad", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-04 12:20:00"}